Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA guidances

This article was originally published in The Gray Sheet

Executive Summary

Comments are due by July 18 on guidance documents for 510(k) submissions for permanent pacemaker leads, vascular prostheses, annuloplasty rings, extracorporeal blood circuit defoamers, cardiopulmonary bypass arterial line blood filters and oxygenators. The six devices were among 38 preamendments devices slated for reclassification from Class III to Class II in a March 15, 1999 proposed rule. Reclassification of the six devices has been put on hold, however, until the guidance documents are finalized (1"The Gray Sheet" June 28, 1999, p. 21)

Latest Headlines
See All
UsernamePublicRestriction

Register

MT013274

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel